How This Multi-Million Dollar Startup Could Make It Easier To Identify The Next Epidemic

Karius is a liquid biopsy company for infectious diseases, and they can detect DNA from invading pathogens before patients show symptoms.

Read the full post on Forbes - Healthcare

Leah Rosenbaum, Forbes Staff